<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR214">
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Zoratti</surname>
    <given-names>GL</given-names>
   </name>
   <name>
    <surname>Tanabe</surname>
    <given-names>LM</given-names>
   </name>
   <name>
    <surname>Varela</surname>
    <given-names>FA</given-names>
   </name>
   <name>
    <surname>Murray</surname>
    <given-names>AS</given-names>
   </name>
   <name>
    <surname>Bergum</surname>
    <given-names>C</given-names>
   </name>
   <name>
    <surname>Colombo</surname>
    <given-names>E</given-names>
   </name>
   <name>
    <surname>Lang</surname>
    <given-names>JE</given-names>
   </name>
   <name>
    <surname>Molinolo</surname>
    <given-names>AA</given-names>
   </name>
   <name>
    <surname>Leduc</surname>
    <given-names>R</given-names>
   </name>
   <name>
    <surname>Marsault</surname>
    <given-names>E</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Targeting matriptase in breast cancer abrogates tumour progression via impairment of stromal-epithelial growth factor signalling</article-title>
  <source>Nat Commun</source>
  <year>2015</year>
  <volume>6</volume>
  <fpage>6776</fpage>
  <pub-id pub-id-type="doi">10.1038/ncomms7776</pub-id>
  <?supplied-pmid 25873032?>
  <pub-id pub-id-type="pmid">25873032</pub-id>
 </element-citation>
</ref>
